Document is current
Any future updates will be listed below
-
Authors
Feng, Shuo
Phillips, Daniel J. https://orcid.org/0000-0003-0686-5091
White, Thomas
Sayal, Homesh
Aley, Parvinder K.
Bibi, Sagida
Dold, Christina
Fuskova, Michelle https://orcid.org/0000-0002-2146-4299
Gilbert, Sarah C. https://orcid.org/0000-0002-6823-9750
Hirsch, Ian
Humphries, Holly E.
Jepson, Brett
Kelly, Elizabeth J.
Plested, Emma
Shoemaker, Kathryn
Thomas, Kelly M. https://orcid.org/0000-0002-0348-654X
Vekemans, Johan
Villafana, Tonya L.
Lambe, Teresa https://orcid.org/0000-0001-7711-897X
Pollard, Andrew J. https://orcid.org/0000-0001-7361-719X
Voysey, Merryn https://orcid.org/0000-0001-6324-6559
,
Adlou, Syed
Allen, Lauren
Angus, Brian
Anslow, Rachel
Asselin, Marie-Claude
Baker, Natalie
Baker, Philip
Barlow, Thomas
Beveridge, Amy
Bewley, Kevin R.
Brown, Phillip
Brunt, Emily
Buttigieg, Karen R.
Camara, Susana
Charlton, Sue
Chiplin, Emily
Cicconi, Paola
Clutterbuck, Elizabeth A.
Collins, Andrea M.
Coombes, Naomi S.
Clemens, Sue Ann Costa
Davison, Melanie
Demissie, Tesfaye
Dinesh, Tanya
Douglas, Alexander D.
Duncan, Christopher J. A.
Emary, Katherine R. W.
Ewer, Katie J.
Felle, Sally
Ferreira, Daniela M.
Finn, Adam
Folegatti, Pedro M.
Fothergill, Ross
Fraser, Sara
Garlant, Harriet
Gatcombe, Laura
Godwin, Kerry J.
Goodman, Anna L.
Green, Christopher A.
Hallis, Bassam
Hart, Thomas C.
Heath, Paul T.
Hill, Helen
Hill, Adrian V. S.
Jenkin, Daniel
Kasanyinga, Mwila
Kerridge, Simon
Knight, Chanice
Leung, Stephanie
Libri, Vincenzo
Lillie, Patrick J.
Marinou, Spyridoula
McGlashan, Joanna
McGregor, Alastair C.
McInroy, Lorna
Minassian, Angela M.
Mujadidi, Yama F.
Penn, Elizabeth J.
Petropoulos, Christos J.
Pollock, Katrina M.
Proud, Pamela C.
Provstgaard-Morys, Samuel
Rajapaska, Durga
Ramasamy, Maheshi N.
Sanders, Katherine
Shaik, Imam
Singh, Nisha
Smith, Andrew
Snape, Matthew D.
Song, Rinn
Shrestha, Sonu
Sutherland, Rebecca K.
Thomson, Emma C.
Turner, David P. J.
Webb-Bridges, Alice
Wrin, Terri
Williams, Christopher J.
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (NA)
- License Information
-
More Information
Article History
Received: 21 June 2021
Accepted: 14 September 2021
First Online: 29 September 2021
Competing interests
: Oxford University has entered into a partnership with AstraZeneca for further development of ChAdOx1 nCoV-19. S.C.G. is a cofounder of Vaccitech (collaborators in the early development of this vaccine candidate) and named as an inventor on a patent covering use of ChAdOx1 vectored vaccines and a patent application covering this SARS-CoV-2 vaccine (PCT/GB2012/000467). T.L. is named as an inventor on a patent application covering this SARS-CoV-2 vaccine and was a consultant to Vaccitech for an unrelated project during the conduct of the study. A.J.P. is chair of the UK Department of Health and Social Care (DHSC) Joint Committee on Vaccination & Immunisation (JCVI) but does not participate in discussions on COVID-19 vaccines, and is a member of WHO SAGE. The views expressed in this article do not necessarily represent the views of the DHSC, JCVI, NIHR, or WHO. T.W., H.S., I.H., J.B., E.J.K., K.S., J.V., and T.L.V. are employees of AstraZeneca. The other authors declare no competing interests.
